Indication
Genital
4 clinical trials
6 products
Clinical trial
A Phase 3, Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9vHPV Vaccine in Japanese Males, 16 to 26 Years of Age.Status: Active (not recruiting), Estimated PCD: 2025-01-30
Product
V503Clinical trial
IL-4 and IFN-γ as Immunologic Predictors of Response to HPV Immunotherapy in WartsStatus: Completed, Estimated PCD: 2020-07-03
Product
IL-4 and IFN-γ measurementsClinical trial
Efficacy and Safety of Vaginal Suppositories Containing Combination of Natamycin and Lactulose in Treatment of Vulvovaginal Candidiasis: International, Randomized, Controlled, Superiority Clinical TrialStatus: Completed, Estimated PCD: 2023-07-26
Product
Natamycin + LactuloseProduct
LactuloseProduct
PimafucinClinical trial
Therapeutic Intralesional Nonavalent HPV Vaccine for Genital Condylomata in Adults: an Open Label Pilot StudyStatus: Recruiting, Estimated PCD: 2024-07-01